Claris Law Legal Blogging Community

Recent Entries

RSS 2.0 feed Add to My Yahoo!
Add to Bloglines Add to your My Feedster
Add to your NewsGator My MSN
Ketek Lawyers

Ketek News

News about the antibiotic Ketek, which has been linked to liver failure and a dozen deaths.

editor photo

Editor: Ketek Lawyer
Profession: Attorney at Law

December 15, 2006

By Staff Writer

TrackBack (0)

Iraq War Veteran Suffers Liver Disease on Ketek

Category: Ketek News

Doctors have diagnosed Iraq War Veteran Chuck Gregg with "drug induced hepatits" after using Ketek. Gregg says he was in the hospital just five days after being prescribed the powerful antibiotic.

Gregg says he had no history of liver problems and was in good health prior to using Ketek. "He survived 13 months in Iraq... to come home for this," says Sherry Gregg, his wife.

More disturbing is what some believe may be an FDA cover up of indications that the drug posed serious dangers to some.

Continue reading "Iraq War Veteran Suffers Liver Disease on Ketek"

December 13, 2006

By Staff Writer

TrackBack (0)

Senator Grassley's Ketek Report Highly Critical of FDA

Category: Ketek News

Senator Charles Grassley, who has been investigating the FDA's clinical safety trials of the antibiotic drug Ketek, attempted to block the confirmation of Andrew Von Eschenbach as FDA commissioner last week. Grassley believes Von Eschenbach sought to impede his investigation into the the drug's trials. Ketek has been linked to fatal liver failure and possibly heart rhythm problems in some patients. According to Grassley, who spoke to the senate last week,

"The way the FDA under this nominee has handled the investigation of Ketek shows the agency would like to keep its business secret. It doesn't want these issues made public or subjected to the scrutiny."

Doug Greene, a doctor working for Sanofi-Aventis, the drug's manufacturer, insists the drug is safe enough for use, despite it's being on Public Citizen Health Watch's "Do Not Use" list since the summer of 2004. Ketek, which is also known as telithromycin, had $200 Million in sales in 2005.

June 30, 2006

By Staff Writer

TrackBack (0)

FDA Prompts Revised Ketek Label for Liver Damage

Category: Ketek News

On June 29, 2006, the FDA completed a safety assessment of Ketek (telithromycin), notifying patients and physicians of rare but potentially serious risks associated with the drug, including severe liver problems and failure.

Since its 2004 FDA approval, Ketek has been linked to liver injury and failure in some cases, including four deaths and one liver transplant reported among Ketek users. Ketek's maker, Sanofi Aventis, plans to revise the drug's label to address these risks and concerns.

Continue reading "FDA Prompts Revised Ketek Label for Liver Damage"

June 28, 2006

By Staff Writer

TrackBack (0)

Ketek Warnings

Category: Ketek News

Ketec is in a class of antibiotics known to be toxic to the liver. One must wonder why the original warnings for the medication did not make this clear.